GB202001381D0 - Probiotic formulation and delivery - Google Patents

Probiotic formulation and delivery

Info

Publication number
GB202001381D0
GB202001381D0 GBGB2001381.9A GB202001381A GB202001381D0 GB 202001381 D0 GB202001381 D0 GB 202001381D0 GB 202001381 A GB202001381 A GB 202001381A GB 202001381 D0 GB202001381 D0 GB 202001381D0
Authority
GB
United Kingdom
Prior art keywords
delivery
probiotic formulation
probiotic
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2001381.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proagni Pty Ltd
Austrianova Singapore Pte Ltd
Original Assignee
Proagni Pty Ltd
Austrianova Singapore Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proagni Pty Ltd, Austrianova Singapore Pte Ltd filed Critical Proagni Pty Ltd
Priority to GBGB2001381.9A priority Critical patent/GB202001381D0/en
Publication of GB202001381D0 publication Critical patent/GB202001381D0/en
Priority to CA3169611A priority patent/CA3169611A1/en
Priority to EP21747327.1A priority patent/EP4096426A4/en
Priority to IL295217A priority patent/IL295217A/en
Priority to BR112022015098A priority patent/BR112022015098A2/en
Priority to PCT/AU2021/050064 priority patent/WO2021151161A1/en
Priority to AU2021213029A priority patent/AU2021213029A1/en
Ceased legal-status Critical Current

Links

GBGB2001381.9A 2020-01-31 2020-01-31 Probiotic formulation and delivery Ceased GB202001381D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB2001381.9A GB202001381D0 (en) 2020-01-31 2020-01-31 Probiotic formulation and delivery
CA3169611A CA3169611A1 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
EP21747327.1A EP4096426A4 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
IL295217A IL295217A (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
BR112022015098A BR112022015098A2 (en) 2020-01-31 2021-01-29 PROBIOTICS FORMULATION AND DELIVERY
PCT/AU2021/050064 WO2021151161A1 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery
AU2021213029A AU2021213029A1 (en) 2020-01-31 2021-01-29 Probiotic formulation and delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2001381.9A GB202001381D0 (en) 2020-01-31 2020-01-31 Probiotic formulation and delivery

Publications (1)

Publication Number Publication Date
GB202001381D0 true GB202001381D0 (en) 2020-03-18

Family

ID=69800135

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2001381.9A Ceased GB202001381D0 (en) 2020-01-31 2020-01-31 Probiotic formulation and delivery

Country Status (1)

Country Link
GB (1) GB202001381D0 (en)

Similar Documents

Publication Publication Date Title
IL270812B1 (en) Solid compositions for oral administration comprising semaglutide and dapagliflozin and their use in medicine
GB2595109B (en) Pharmaceutical delivery compositions and uses thereof
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
PT3432970T (en) In vivo drug delivery devices and methods for drug delivery
IL311331A (en) Pharmaceutical composition and use thereof
EP4096426A4 (en) Probiotic formulation and delivery
IL312874A (en) Pharmaceutical composition and use thereof
EP3982942A4 (en) Drug delivery methods and compositions
GB201809909D0 (en) Preparation and formulation of drinks
GB201905386D0 (en) Probiotic compositions and uses thereof
EP3621659A4 (en) Drug delivery composition and method of fabrication
GB202001381D0 (en) Probiotic formulation and delivery
IL271596A (en) Compositions for drug delivery and methods of use thereof
GB202309892D0 (en) Product delivery devices and methods
GB2602870B (en) Concrete formulation and products manufactured therefrom
AU2020900269A0 (en) Probiotic formulation and delivery
IL284120A (en) Ready-to-use probiotic compositions and uses thereof
GB201908154D0 (en) Lactobacillus compositions and uses thereof
GB202210523D0 (en) Probiotic compositions and therapeutic uses thereof
EP4125873A4 (en) Pharmaceutical compositions and use thereof
GB201905389D0 (en) Probiotic compositions and uses
HK1254527A1 (en) Pharmaceutical formulation and use thereof
GB201908706D0 (en) Lactobacillus compositions and uses thereof
SG11202106147RA (en) Lactobacillus fermentum wikim0102 having anti-cancer activity and composition comprising the same as active ingredient
IL267690A (en) Magnesium-containing formulation and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)